Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Breast Neoplasms 79Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 5Breast Neoplasms, Male 4Neoplasm Metastasis 3Breast Carcinoma In Situ 3Arthralgia 3Triple Negative Breast Neoplasms 2Sexual Dysfunction, Physiological 1Seizures 1Recurrence 1Pain 1Osteoporosis 1Obesity 1Multiple Endocrine Neoplasia Type 1 1Lethal Congenital Contracture Syndrome 2 1Joint Diseases 1Invasive Breast Cancer 1Hypogonadism 1Granulosa Cell Ovarian Cancer 1Fractures, Bone 1Erectile Dysfunction 1Epilepsy 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Metastatic 1Advanced Metastatic Breast Cancer 1Advanced Breast Carcinoma 1

Interventions

Radiotherapy 2Vitamin D 1Testosterone 1Tadalafil 1Radiosurgery 1Pilocarpine 1Phenylephrine 1Lidocaine 1Hormonal Contraception 1Estradiol 1Drug Therapy 1Dehydroepiandrosterone 1Arginine 1ArginMax 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sexual Dysfunction, Physiological × Anastrozole × Clear all
NCT00179517 2019-07-17

Treatment of Sexual Dysfunction in Hypogonadal Men With Epilepsy With Testosterone and Either Anastrozole or Placebo

Beth Israel Deaconess Medical Center

Phase 2 Completed
40 enrolled 13 charts
EndocrineOther

Epilepsy, Hypogonadism, Erectile Dysfunction, Seizures, Sexual Dysfunction, Physiological, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡